100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
477600-73-0Tofacitinib Benzyl Impurity
● Auf Lager
| Katalog-Nr.:: | VE006715 |
|---|---|
| CAS-Nr.:: | 477600-73-0 |
| Summenformel:: | C20H25N5 |
| Molare Masse:: | 335.45 |
Zusätzliche Informationen zu CAS 477600-73-0
Parent drug
TofacitinibIUPAC-Name
N-((3R, 4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amineSynonyme
Tofacitinib Inhouse Impurity B/ Des-(N-oxopropanenitrile)-N-methylbenzylBeschreibung
Also known as Tofacitinib Inhouse Impurity B or Des-(N-oxopropanenitrile)-N-methylbenzyl, it is an impurity of Tofacitinib, Tofacitinib is a novel oral Janus Kinase (JAK) inhibitor, used in the treatment of myeloproliferative disorders.Angebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Tofacitinib impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
![Butyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate](https://veeprho.com/wp-content/uploads/2022/11/Butyl-4-cyano-3-imino-5-3R-4R-4-methyl-3-methyl-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-5-oxopentanoate.png "Butyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate")
Tofacitinib
CAS No. N/A
Cat No. VE0010254
![Ethyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate](https://veeprho.com/wp-content/uploads/2022/11/Ethyl-4-cyano-3-imino-5-3R-4R-4-methyl-3-methyl-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-5-oxopentanoate.png "Ethyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate")
Tofacitinib
CAS No. 2102039-99-4
Cat No. VE0010253
![N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/wp-content/uploads/2023/02/N-methyl-N-3S-4S-4-methyl-1-nitrosopiperidin-3-yl-7-nitroso-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidin-4-amine.png "N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
Cat No. VE0011036
![N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/wp-content/uploads/2023/02/N-methyl-N-3S-4S-4-methyl-1-nitrosopiperidin-3-yl-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidin-4-amine.png "N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine
Cat No. VE0011034
